Sanuwave Health (SNWV) Competitors $38.81 -0.94 (-2.36%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock SNWV vs. NVCR, CDRE, BLFS, ESTA, PLSE, MDXG, INMD, IRMD, KMTS, and EMBCShould you be buying Sanuwave Health stock or one of its competitors? The main competitors of Sanuwave Health include NovoCure (NVCR), Cadre (CDRE), BioLife Solutions (BLFS), Establishment Labs (ESTA), Pulse Biosciences (PLSE), MiMedx Group (MDXG), InMode (INMD), iRadimed (IRMD), Kestra Medical Technologies (KMTS), and Embecta (EMBC). These companies are all part of the "medical equipment" industry. Sanuwave Health vs. Its Competitors NovoCure Cadre BioLife Solutions Establishment Labs Pulse Biosciences MiMedx Group InMode iRadimed Kestra Medical Technologies Embecta NovoCure (NASDAQ:NVCR) and Sanuwave Health (NASDAQ:SNWV) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation. Do analysts recommend NVCR or SNWV? NovoCure presently has a consensus target price of $28.79, suggesting a potential upside of 138.29%. Sanuwave Health has a consensus target price of $55.00, suggesting a potential upside of 41.72%. Given NovoCure's higher probable upside, analysts plainly believe NovoCure is more favorable than Sanuwave Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NovoCure 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57Sanuwave Health 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is NVCR or SNWV more profitable? NovoCure has a net margin of -27.13% compared to Sanuwave Health's net margin of -97.03%. Sanuwave Health's return on equity of 0.00% beat NovoCure's return on equity.Company Net Margins Return on Equity Return on Assets NovoCure-27.13% -47.74% -13.79% Sanuwave Health -97.03%N/A -135.15% Does the media refer more to NVCR or SNWV? In the previous week, NovoCure and NovoCure both had 4 articles in the media. Sanuwave Health's average media sentiment score of 1.03 beat NovoCure's score of 0.71 indicating that Sanuwave Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NovoCure 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Sanuwave Health 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better earnings & valuation, NVCR or SNWV? Sanuwave Health has lower revenue, but higher earnings than NovoCure. NovoCure is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNovoCure$605.22M2.23-$168.63M-$1.56-7.74Sanuwave Health$32.63M10.19-$31.37M-$8.25-4.70 Which has more risk & volatility, NVCR or SNWV? NovoCure has a beta of 0.58, suggesting that its stock price is 42% less volatile than the S&P 500. Comparatively, Sanuwave Health has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500. Do insiders and institutionals hold more shares of NVCR or SNWV? 84.6% of NovoCure shares are owned by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are owned by institutional investors. 5.5% of NovoCure shares are owned by insiders. Comparatively, 14.9% of Sanuwave Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummarySanuwave Health beats NovoCure on 8 of the 15 factors compared between the two stocks. Get Sanuwave Health News Delivered to You Automatically Sign up to receive the latest news and ratings for SNWV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SNWV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNWV vs. The Competition Export to ExcelMetricSanuwave HealthMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$332.60M$10.64B$5.75B$9.83BDividend YieldN/A1.84%6.66%4.49%P/E Ratio-4.7021.5282.4426.63Price / Sales10.1929.16530.80110.54Price / CashN/A25.1325.7028.92Price / Book-22.563.4010.646.56Net Income-$31.37M$211.94M$3.28B$266.04M7 Day Performance-12.47%-2.20%-0.08%-0.58%1 Month Performance7.09%11.27%10.36%6.24%1 Year PerformanceN/A-8.37%49.00%22.21% Sanuwave Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNWVSanuwave Health2.3892 of 5 stars$38.81-2.4%$55.00+41.7%N/A$332.60M$32.63M-4.7040News CoveragePositive NewsAnalyst ForecastNVCRNovoCure3.9834 of 5 stars$12.43+4.4%$28.79+131.6%-37.3%$1.33B$605.22M-7.971,488News CoverageCDRECadre3.3882 of 5 stars$30.99+4.6%$31.50+1.7%-14.8%$1.20B$567.56M32.962,284Positive NewsBLFSBioLife Solutions1.7687 of 5 stars$25.91+3.3%$31.29+20.7%-2.1%$1.20B$82.25M-215.90440ESTAEstablishment Labs2.0863 of 5 stars$43.63+9.1%$56.50+29.5%-12.0%$1.16B$177.42M-14.301,018News CoveragePositive NewsPLSEPulse Biosciences4.0137 of 5 stars$17.05+6.6%$22.00+29.0%-18.9%$1.08B$700K-16.24140News CoveragePositive NewsMDXGMiMedx Group3.4447 of 5 stars$7.31+4.0%$12.00+64.2%+5.1%$1.04B$363.77M34.81870News CoveragePositive NewsINMDInMode3.1511 of 5 stars$14.81+4.2%$18.04+21.8%-13.8%$898.20M$394.82M6.00480Positive NewsIRMDiRadimed4.8259 of 5 stars$72.66+3.0%$72.00-0.9%+52.5%$897.14M$73.24M44.85110News CoverageKMTSKestra Medical Technologies1.3453 of 5 stars$18.58+8.9%$27.33+47.1%N/A$876.01M$59.81M0.00300News CoveragePositive NewsLockup ExpirationEMBCEmbecta4.6162 of 5 stars$14.38+4.0%$19.00+32.1%-10.5%$808.85M$1.12B10.062,100Positive News Related Companies and Tools Related Companies NVCR Competitors CDRE Competitors BLFS Competitors ESTA Competitors PLSE Competitors MDXG Competitors INMD Competitors IRMD Competitors KMTS Competitors EMBC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNWV) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanuwave Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanuwave Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
